RAP1A / Ras-related protein Rap-1A · Western blot design guide

Design a Western Blot for RAP1A

Real validated RAP1A Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAP1A WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RAP1A: expected band ~21 kDa, hero antibody PB9816, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable RAP1A Western blot protocol sheet — expected band ~21 kDa, antibody PB9816, controls and PMC citations. Open the full RAP1A WB guide →

RAP1A Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~21 kDa
Observed band ≈21 kDa
Gel 5–20% (catalog PB9816)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Methylated + Cleaved
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated RAP1A Western Blot Protocols

The PB9816 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateRat Brain, Rat Liver, Rat Kidney (catalog PB9816)
Gel %5–20% (catalog PB9816)
Load50ug; reducing conditions (catalog PB9816)
Transfera Nitrocellulose membrane at 150mA for 50-90 minutes (catalog PB9816)
MembraneNitrocellulose membrane (catalog PB9816)
Blocking5% Non-fat Milk/ TBS for 1.5 hour at RT (catalog PB9816)
Primary antibodyPB9816 · 0.5 μg/mL (catalog PB9816)
Primary incubationovernight at 4°C (catalog PB9816)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:10000 (catalog PB9816)
Secondary incubation1.5 hour at RT (catalog PB9816)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog PB9816)
DetectionECL (catalog PB9816)
Section 2

What Is the Expected RAP1A Western Blot Band Size?

RAP1A is predicted at 21 kDa and observed at approximately 21 kDa; its listed processing and modifications have no established visible shift.

What am I looking at on my blot?
Band at approximately 21 kDamatches the empirical RAP1A band and its predicted mass
Band near 21 kDa in a membrane fractionconsistent with membrane-associated RAP1A
Band near 21 kDa in a cytoplasmic fractionconsistent with cytoplasmic RAP1A
Band slightly below a precursor bandcould reflect cleavage of the three-residue propeptide, if the difference is resolvable
💡Expected RAP1A appearanceRAP1A has a predicted mass of 21 kDa and an empirical band at approximately 21 kDa; confirm band identity with a positive control and RAP1A depletion when needed.
How each factor affects band size
Predicted RAP1A masspredicts a band near 21 kDa, matching the observed approximately 21 kDa band
Propeptide at residues 182–184cleavage could make mature RAP1A slightly smaller than its precursor; visible separation is unproven
Cysteine methyl ester at residue 181adds a small modification without an established visible band shift
Prenylation and lipid anchoringmay affect migration, but no shift is established by the supplied evidence
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatemembrane-associated RAP1A may be poorly extractedcheck lysis conditions and a membrane-enriched fraction
Band higher than expectedthe identity of a band well above 21 kDa is uncertaincompare with a positive control and test RAP1A depletion
Band lower than expectedthree-residue propeptide cleavage predicts only a small mass changeverify a substantially lower band by RAP1A depletion
Multiple bandsadditional bands are not explained by the single listed isoformcompare with a positive control and test RAP1A depletion
Weak or no signalrecovery may vary between membrane and cytoplasmic fractionscheck extraction and loading in both fractions
Fragments below expected sizesample proteolysis may produce smaller bandsprepare fresh lysate with protease inhibitors and check whether fragments diminish

Sample controls for RAP1A Western blot

🧪For positive controls for RAP1A in Western blot, you can use a tissue or cell line after confirming RAP1A expression; HPA provides no positive candidate.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HPA data are unavailable, so tissue controls cannot be verified; use knockdown or KO to assess specificity.

HPA tissue expression evidence for RAP1A

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced RAP1A Western Blot Tips

Deeper troubleshooting and optimisation questions for RAP1A, answered from its protein features.

How should RAP1A band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could annotated isoforms account for multiple RAP1A bands?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no isoform-based explanation for multiple bands.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of RAP1A?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for RAP1A?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the PB9816 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should RAP1A bands be quantified across fractions?
Quantitation · Because RAP1A is annotated in membrane and cytoplasmic locations, compare like fractions prepared the same way. Record whether measurements come from whole-cell material or an enriched fraction before interpreting intensity differences.
Should RAP1A migrate at its predicted 21 kDa?
Interpretation · The predicted mass and reported apparent band are both about 21 kDa. Use that region as a starting point for identification; a matching position alone does not establish band identity.

UniProt lists a propeptide at residues 182–184 and a cysteine methyl ester at residue 181, using UniProt numbering. Neither feature alone demonstrates a visible shift or explains a difference between calculated and apparent mass.

RAP1A is annotated at the cell membrane with a lipid anchor, and also in the cytoplasm and perinuclear region. Check which fraction your preparation retains when comparing band intensity across samples.

First compare them with the reported approximately 21 kDa band. The record lists residue 181 methylation, a propeptide at 182–184, and one isoform, but these annotations do not identify an unexpected band or establish a visible mobility shift.
Boster reagents

RAP1A Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of RAP1A using anti-RAP1A antibody (PB9816). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. Lane 1: Rat Brain Tissue Lysate, Lane 2: Rat Liver Tissue Lysate, Lane 3: Rat Kidney Tissue Lysate, Lane 4: MCF-7 Whole Cell Lysate, Lane 5: SW620 Whole Cell Lysate. After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-RAP1A antigen affinity purified polyclonal antibody (Catalog # PB9816) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for RAP1A at approximately 21KD. The expected band size for RAP1A is at 21KD.
Anti-RAP1A Antibody Picoband®
Cat # PB9816

PB9816 is an anti-RAP1A antibody listed for human, mouse, and rat. Its Western blot image shows an approximately 21 kDa band in rat brain, liver, and kidney lysates and MCF-7 and SW620 cell lysates. No mouse sample is shown.

Which to pick: PB9816 is the only listed option and has a Western blot image. Choose it when its reported reactivity and tested samples fit your experiment; mouse reactivity is listed, but the supplied image does not test a mouse sample.

Source: BosterBio RAP1A gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.